170496 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
GENETICALLY ENCODED BIOLUMINESCENT SENSORS
#2METHODS OF TREATING EPILEPSY
#3METHODS AND SYSTEMS FOR IDENTIFYING OR TREATING CENTRAL NERVOUS SYSTEMS DISEASE
#4METHODS OF USE OF ANTI-SORTILIN ANTIBODIES
#5ANTI-NMDA RECEPTOR ANTIBODIES AND METHODS OF USE
#6EXPRESSION SYSTEMS FOR THE ALPHA6-CONTAINING NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF
#7METHOD OF INHIBITING TAU PHOSPHORYLATION
#8BIOMARKERS AND THEIR USE IN DIAGNOSING PARKINSON'S DISEASE, VITREORETINAL DISEASES, AND AGE-RELATED PATHOLOGIES
#9METHOD OF INHIBITING TAU PHOSPHORYLATION
#10DETECTING AND DIFFERENTIATING NEUROTRANSMITTERS USING ULTRAVIOLET PLASMONIC-ENGINEERED NATIVE FLUORESCENCE
#11DIAGNOSIS AND TREATMENT OF ECTOPIC ENDOMETRIOSIS
#12PARKINSON'S SYNDROME MARKER AND USE THEREOF
#13METHOD OF INHIBITING TAU PHOSPHORYLATION
#14COMPOSITIONS AND METHODS OF INHIBITING THE BINDING OF PLASMA IGG AUTOANTIBODIES TO SEROTONIN 2A RECEPTOR
#15BIOSENSORS FOR DETECTING CHANGES IN THE LEVEL OF A NEUROTRANSMITTER IN THE CENTRAL NERVOUS SYSTEM
#16NMDA RECEPTOR CONSTRUCTS TO DETECT AND ISOLATE NMDAR AUTOANTIBODIES
#17Methods of treating epilepsy
#18Assembly of functionally integrated human forebrain spheroids and methods of use thereof
#19Anti-NMDA receptor antibodies and methods of use
#20Alzheimer's Disease Assay in a Living Patient
#21SCREENING METHOD FOR THERAPEUTIC DRUG OR PROPHYLACTIC DRUG FOR TAUOPATHY AND DIAGNOSTIC METHOD FOR TAUOPATHY
#22nicotinic acetylcholine receptor and pest control acting thereon
#23nAChR-alpha7 Agonists and nAChR-alpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn's Disease (CD)
#24Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer
#25Method of inhibiting tau phosphorylation
#26Diagnosis and therapy of multiple sclerosis
#27Assembly of functionally integrated human forebrain spheroids and methods of use thereof
#28PHARMACEUTICAL COMPOSITION FOR INDUCING EXERCISE MIMETIC EFFECT
#29Circulating astrocytes and MFSD2A as biomarkers
#30Alzheimer's disease assay in a living patient
#31HIGH THROUGHPUT SCREENING OF AGENTS ON DOPAMINERGIC NEURONS
#32METHODS AND COMPOSITIONS FOR NICOTINIC RECEPTOR ASSAYS
#33Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment
#34Molecules in the tryptophan-5-hydroxytryptophan-serotonin-NAS-melatonin/6-hydroxymelatonin sulfate-melatonin receptor 1A pathway in neurological diseases
#35ANTIBODY OR ANTIBODY FRAGMENT OF NON-IG SCAFFOLD BINDING TO A BINDING REGION OF AN ANTI-N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTIBODY
#36Circulating astrocytes and MFSD2A as biomarkers
#37Methods for diagnosing and treating Alzheimers disease using G72 protein and SLC7A11 mRNA as biomarkers
#38MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS
#39MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS
#40Mu opioid receptor agonist analogs of the endomorphins
#41Agonists of the mu opioid receptor
#42METHODS AND COMPOSITIONS FOR TREATMENT OR DIAGNOSIS OF CANCERS RELATED TO GABRA3
#43Method for detecting GABAA receptor autoantibodies
#44METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS
#45Diagnosis and therapy of multiple sclerosis
#46Methods for detecting autoantibodies against a GABA(A) receptor alpha 1 subunit and/or beta 3 subunit in autoimmune seizure and/or encephalitis
#47Alzheimer's disease assay in a living patient
#48Inhibitors Of Fatty Acid Amide Hydrolase And Monoacylglycerol Lipase For Modulation Of Cannabinoid Receptors
#49PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE
#50HIGH THROUGHPUT SCREENING OF AGENTS ON DOPAMINERGIC NEURONS
#51Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#52α-conotoxin peptide, pharmaceutical composition and use thereof
#53Modified peptide, CB receptor ligand, kit in vitro process for evaluating CB receptor bonds, uses, pharmaceutical composition for modulating CB receptor activity
#54GAMMA-AMINOBUTYRIC ACID A RECEPTOR SUBUNIT BIOMARKERS
#55Methods for diagnosing and treating neuroendocrine cancer
#56Protein chips, preparation and use thereof
#57Phenylethanolamine-based NMDA receptor antagonists
#58Methods for diagnosing and treating neuroendocrine cancer
#591,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
#60Alzheimer's disease assay in a living patient
#61Alzheimer's disease assay in a living patient
#62Method for manufacturing an analysis substrate, and use thereof for detecting toxins
#63Treatment of penetrative injury to the brain
#64Daikenchuto bioassay method and quality management method using same
#65Mu opioid receptor agonist analogs of the endomorphins
#66Phenylethanolamine-based NMDA receptor antagonists
#67Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#68Dopaminergic neuron progenitor cell marker 187A5
#69Methods for diagnosing and treating encephalitis or epilepsy
#70Small interfering RNAs and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer
#71Caged Neuropeptides: modulation and measurement of synapse and signaling activity; and methods for drug evaluation, pharmaceuticals preparation and treatment
#72Molecular Interactions in Hematopoietic Cells
#73Conformation-selective nucleic acid inhibitors of AMPA glutamate receptors
#74NMDAR BIOMARKERS FOR DIAGNOSING AND TREATING CEREBRAL ISCHEMIA
#75Label-free Cellular Pharmacology For Drug Antitarget Assessment
#76PROCESS FOR IDENTIFYING DRUGS FOR TREATING GASTROESOPHAGEAL REFLUX
#77Drug-Enhanced Neurofeedback
#78Methods and compositions related to acetylocholine receptor conjugates
#79Pharmaceutical compositions and their methods of use
#80Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors
#81Method of bioassaying yokukansan
#82Methods for diagnosing and treating neuroendocrine cancer
#83Methods for diagnosing and treating neuroendocrine cancer
#84Dopaminergic neuron progenitor cell marker 187A5
#85Bioassay method for yokukansan with serotonin receptor
#86Indazole-carboxamide compounds as 5-HTreceptor agonists
#87Inhibitors of PDE4 and Methods of Use
#88Assays utilizing nicotinic acetylcholine receptor subunits
#89NMDAR Biomarkers for Diagnosing and Treating Cerebral Ischemia
#90Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#91Method of Screening Compounds Having Anti-Amyloid Properties
#92CONUS POLYPEPTIDES
#93Use of hematopoietic growth factor inducible neurokinin-1 (HGFIN) as a biomarker for renal injury or renal disease
#94METHOD OF DIAGNOSING A NEURODEGENERATIVE DISEASE
#95Amyloid beta receptor and uses thereof
#96Single-cell biosensor for the measurement of GPCR ligands in a test sample
#97ESSENTIAL TREMOR DIAGNOSTIC AND TREATMENT
#98Methods for diagnosis of encephalitis
#99Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
#100Single-cell biosensor for the measurement of GPCR ligands in a test sample
#101Methods for diagnosing and treating neuroendocrine cancer
#102Ultra sensitive biosensor for detecting bio-signal transmitters, and detector and detecting method using the same
#103MECHANISM OF ASTRICYTE-NEURON SIGNALING
#104Methods of identifying a compound that increases or decreases the interaction of Hn-33 with synaptotagmin II
#105Method for screening for agents that affect food intake
#106Trace amine receptor 1 of the african green monkey
#107Homo and Heterodimer Proteins of the Abcg Family, Methods For Detection and Screening Modulators Thereof
#108METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR
#109Pharmaceutical compositions and their methods of use
#110Indazole-carboxamide compounds as 5-HTreceptor agonists
#111Bicyclic and Tricyclic Heteroaromatic Compounds
#112Cellular antagonists of GPCR physiology
#113Method for selecting allosteric regulators of class III G protein-coupled receptors
#114Human Neuropeptide Receptor
#115Protecting group for carboxylic acids that can be photolyzed by visible light
#116Methods for treating irritable bowel syndrome
#117Endogenous and non-endogenous version of human G protein-coupled receptors
#118Upstream control elements of the proopiomelanocortin gene and their use
#119Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
#120Mouse with deficiency of glutamate transporter GLAST function
#121Methods for identifying cell surface receptor protein modulators
#122Novel assays utilizing nicotinic acetylcholine receptor subunits
#123Methods for manipulating satiety
#124Endogenous and non-endogenous versions of human G protein-coupled receptors
#125Endogenous and non-endogenous versions of human G protein-coupled receptors
#126Bicyclic and tricyclic heteroaromatic compounds
#127Chimeric gaba receptor
#128Selection of pH-dependent compounds for in vivo therapy
#129Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
#130Antibody assay methods to assess risk for TIA/stroke
#131Assay methods for immediate diagnosis of cause of stroke
#132Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#133Glutamate transport modulatory compounds and methods
#134Trace amine receptor 1 of the African green monkey
#135Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor
#136Materials and methods for identifying anti-schizophrenic agents
#137Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
#138Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
#139Interaction of NMDA receptor with protein tyrosine phosphatase
#140Antibodies to human Elk, a voltage-gated potassium channel subunit
#141Indazole-carboxamide compounds as 5-HTreceptor agonists
#142Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
#143Interaction of NMDA receptor with protein tyrosine phosphatase
#144Method for identifying metabotropic glutamate receptor agonists and potentiators
#145Molecular interactions in hematopoietic cells
#146Modulation of signaling pathways
#147Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
#148Fused pyrrolecarboxamides: GABA brain receptor ligands
#149Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia